ClinicalTrials.gg
Not yet recruitingNCT06767878PORTiSOFIEUpdated Jan 10, 2025

Internet Delivered Therapy for Social Anxiety in Adults

An interventional study of PORTiSOFIE in Control Group and Intervention, sponsored by Grupo Lusófona. Not yet recruiting at 1 site in Portugal. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-10.

Sponsored by Grupo Lusófona · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn if an internet-delivered CBT protocol for social anxiety in adults (PORTiSOFIE) is effective in Portugal. It will also learn about the impact that PORTiSOFIE may have on relationship dimensions of these individuals. The main questions it aims to answer are:

Does PORTiSOFIE is effective? What impact PORTiSOFIE has in relationship dimensions?

Participants will:

Be assigned to experimental group and receive intervention briefly after screening is complete; Or control group and only receive intervention after the experimental group finishes.

Read the detailed description

Social Anxiety Disorder (SAD) is a common condition that affects intrapersonal (e.g., distress and impairment) and interpersonal functioning (e.g., difficulties in amorous relationships). People with SAD tend to have difficulties in communicating feelings with partners and report lower levels of relationship and sexual satisfaction. Cognitive behavioral therapy (CBT) for SAD has been found to redcuce symptoms of social anxiety, but less is known about its impact on relationship functioning. Internet-based CBT (iCBT) has gained attention for its primary advantage bridging distances and saving time for the patient. In the planned study the investigators aim to translate and culturally adapt an iCBT program for social anxiety for use in Portugal (PORTiSOFIE) and measure the effects of the program on social anxiety symptoms. The project will also study the impact on relationship satisfaction and other relevant outcomes. The investigators will conduct a randomized controlled trial and divide participants in a two-arm study with parallel groups (i.e., intervention group and wait-list group). Participants will answer questionnaires to assess social anxiety symptoms and relationship outcomes at pre-treatment, posttreatment and 6-month follow up. Participants partner's will also be asked to complete questionnaires on the same periods of time, but only regarding relationship outcomes. iCBT for SAD in adults has not yet been tested in Portugal and overall there is a gap in the literature regarding the role of partners in iCBT for SAD. The study will contribute to increase accessibility to therapy (and better mental health) by promoting online evidence-based therapies. Plus, it will help to better understand how relationship components are affected and affect clinical symptoms and their progression within receiving treatment.

02

Conditions studied

  • Control Group
  • Intervention

Browse trials for

Keywords

  • Social Anxiety
  • internet delivered CBT
  • Relationship satisfaction
  • Sexual satisfaction
03

In context

Orgasm

29 studies on the registry are indexed under Orgasm; 8 are open to participants now.

This study's planned enrollment of 62 is below the median of 80 across 20 interventional studies indexed under Orgasm.

Browse Orgasm studies →

Lead sponsor

Grupo Lusófona is the lead sponsor of 10 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria for participants:

  • Scores on the screening questionnaires indicating at least moderate levels of social anxiety.
  • Age 18 years or over
  • Fluency in Portuguese
  • Access to a device with internet
  • Be in a monogamous amorous relationship (regardless of sexual orientation)
  • Not be receiving any ongoing treatment for social anxiety (e.g., stable antidepressants).

Inclusion Criteria for partners:

  • Age 18 years or over
  • Fluency in Portuguese
  • Access to a device with internet.

Exclusion Criteria:

  • Self-reported severe psychiatric disorders such as psychosis or personality disorder.
  • Planned or ongoing medical treatments (e.g., surgery) and other personal circumstances that will interfere with the treatment (e.g., planned travel abroad).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
62 participants (estimated)

Study arms

  • Experimental
    Intervention Group

    Participants will have access to the treatment (PORTiSOFIE). They will have a logg in for entering the platform and acess the modules, and the measures that need to be filled throughout the study.

    Behavioral: PORTiSOFIE

  • Other
    Attention Group

    The control group will not receive the intervention while the experimental group goes through the protocol. Instead, they will have a weekly checkup with the therapists via the platform to monitor how they are feeling. After the experimental group finishes the intervention, if the PORTiSOFIE demonstrates preliminary indicators of effectiveness, investigators will offer it to the attention group.

    Behavioral: PORTiSOFIE

Interventions

  • BehavioralPORTiSOFIE

    This treatment is based on the Clark and Wells model of social phobia, and it is constituted by 9 modules: 1. Introduction of the program and overview of social anxiety disorder and symptoms 2. Negative automatic thoughts 3. Challenging negative automatic thoughts 4. Behavioral experiments 5. Exposure 6. Exposure and self-focus attention 7. Exposure and get closer to fears 8. Social skill training 9. Maintenance plan

06

What researchers measure

Primary outcomes

  1. Liebowitz Social Anxiety Scale for Adults (LSAS)

    It has 24 items, responded in a 4-point scale. Each item is rated regarding anxiety and avoidance, and so the total score of the scale ranges between 0 and 144, with higher scores indicating higher levels of social anxiety (i.e., below 40 - no discomfort; 40-55 - Mild social discomfort; 55-65 - Moderate social phobia; 65-80 - Marked social phobia; 80-95 - Severe social phobia; Above 95 - Very severe social phobia).

    Time frame: through study completion, an average of 1 year

  2. Social Phobia Inventory (SPIN)

    Is composed by three subscales: fear, avoidance, and physical discomfort. There are 17 items in total (16 in the Portuguese version), assessing the symptoms of the previous. The scale is responded on a 4-point scale, and total score is between zero and 68, with higher scores indicating higher levels of social anxiety.

    Time frame: through study completion, an average of 1 year

  3. Global Measure of Relationship Satisfaction (GMREL)

    Is constituted by 5 items responded in a 7-point Likert scale. Scores range between 5 (low relationship satisfaction) and 35 (high relationship satisfaction).

    Time frame: through study completion, an average of 1 year

  4. Global Measure of Sexual Satisfaction (GMSEX)

    It has 5 items responded in a 7-point Likert scale, with total scores ranging from 5 to 25, with higher values indicating greater sexual satisfaction.

    Time frame: through study completion, an average of 1 year

Secondary outcomes

  1. Revised Dyadic Adjustment Scale (RDAS)

    3 subscales: consensus, satisfaction, cohesion. It is a 14-item measure, that asks people to rate aspects of the relationship on a 5 or 6 point scale. Total scores range between zero and 69, with higher values indicating greater adjustment.

    Time frame: through study completion, an average of 1 year

  2. Inclusion of Other in the Self Scale (IOS)

    A single-item pictorial measure, that measures how close the respondent feels with another person (in this case the amorous partner).

    Time frame: through study completion, an average of 1 year

  3. Difficulties in Interpersonal Emotion Regulation (DIRE)

    It has two subscales: venting and reassurance-seeking, constituted by a total of 24 items. Three hypothetic situations are presented, and for each one, the respondent must indicate how the situation is perceived on a scale from 0 (not at all distress) to 100 (extremely distressed). Then, for each of the scenarios, is asked the likelihood (i.e., 4-point Likert scale) of responding in 7 different presented ways. Higher scores indicate higher levels of difficulties in Interpersonal emotion regulation strategies.

    Time frame: through study completion, an average of 1 year

  4. Personal Assessment of Intimacy in Relationships (PAIR)

    is constituted by 36 items, responded in a 5-point Likert scale (from 1 "strongly disagree" to 5 "strongly agree"), with 18 items being reversed scored, so that higher values correspond to higher levels of intimacy. For the present study, only the communication subscale with 10 items will be used.

    Time frame: through study completion, an average of 1 year

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — Investigators plan to share anonymized data on request

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06767878
Lead sponsor
Grupo Lusófona
Responsible party
Edna Martins (Principal Investigator, Grupo Lusófona) — Principal investigator
First posted
Jan 10, 2025
Start date
Jan 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Jun 2027 (estimated)
Last update
Jan 10, 2025

Study contacts

Edna M Martins
Contact
edna.martins@ulusofona.pt
+351918792199

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion